Immunovia, Inc has received final approval to begin patient testing for the IMMray PanCan-d test.
The IMMray PanCan-d test is the first blood test on the market dedicated to the early detection of pancreatic cancer.
“We are extremely pleased to have achieved this important milestone and to b